Related Experiment Video
Updated: Jan 3, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
'Atypical' Parkinson's disease - genetic
Anne Weissbach1, Christina Wittke1, Meike Kasten2
1Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Genetic atypical Parkinson's disease (PD) involves inherited forms with distinct symptoms. Identifying specific genetic mutations aids in diagnosing these rare PD subtypes and their unique clinical features.
Area of Science:
- Neurology
- Genetics
- Movement Disorders
Background:
- Atypical Parkinson's disease (PD) encompasses monogenic forms presenting with distinct clinical signs.
- These forms can be categorized based on genetic mutations and associated atypical features.
Purpose of the Study:
- To outline the classification and clinical characteristics of genetic atypical Parkinson's disease.
- To highlight key genetic mutations and their corresponding atypical PD phenotypes.
Main Methods:
- Review and synthesis of current literature on genetic atypical Parkinson's disease.
- Classification of genetic PD based on mutation type and clinical presentation.
Main Results:
- Genetic atypical PD is sub-grouped into forms caused by specific gene mutations (e.g., ATP13A2, DCTN1), those resembling idiopathic PD with atypical features (e.g., SNCA, LRRK2), and those linked to other movement disorder genes.
- Common atypical features include early age at onset and cognitive decline.
- Specific red flag symptoms like supranuclear gaze palsy (ATP13A2) or hypoventilation (DCTN1) can indicate particular genetic forms.
Conclusions:
- Genetic atypical Parkinson's disease presents diverse phenotypes driven by specific gene mutations.
- Recognizing shared and distinct atypical features, along with genetic red flags, is crucial for accurate diagnosis and management.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

